Wilmer RM 129, Johns Hopkins University, 600 N Wolfe Street, Baltimore, MD 21205, USA.
Expert Rev Anti Infect Ther. 2012 Jan;10(1):75-83. doi: 10.1586/eri.11.150.
Trachoma, a chronic conjunctivitis caused by Chlamydia trachomatis, is the leading infectious cause of blindness worldwide. In recognition of this public health problem, the World Health Assembly has targeted the year 2020 to eliminate blinding trachoma, and a multifaceted strategy (SAFE) is recommended, including antibiotics for treatment of infection. Trachoma is a disease of entire communities, and the pool of infection resides largely in preschool age children. Thus, for endemic communities, mass treatment with antibiotics annually for at least 3-5 years is carried out. The antibiotics used, the effectiveness of this approach, and the challenges of antibiotic treatment of communities are discussed, concluding with a view towards the elimination of trachoma in the future.
沙眼是由沙眼衣原体引起的慢性结膜炎,是全球致盲的主要传染病原因。认识到这一公共卫生问题,世界卫生大会已将 2020 年定为消除致盲性沙眼的目标,推荐了一种多方面的策略(SAFE),包括抗生素治疗感染。沙眼是整个社区的疾病,感染源主要存在于学龄前儿童中。因此,对于流行地区,每年至少进行 3-5 年的大规模抗生素治疗。本文讨论了所使用的抗生素、这种方法的有效性以及社区抗生素治疗的挑战,最后展望了未来消除沙眼的前景。